author-photo

Elodie Tournay

Institut Gustave Roussy

9

Papers

482

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Reversing resistance to vascular disrupting agents by blocking late mobilization of circulating endothelial progenitor cells

2012 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (44)
A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (50)
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.

2011 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (50)
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent

2011 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (61)
Prognostic Value of Endoscopy in Children With Biliary Atresia at Risk for Early Development of Varices and Bleeding

2010 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (81)
Abstract 372: Circulating endothelial progenitor cell levels predict survival benefit in metastatic renal cell cancer patients treated with antiangiogenic agents

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer

2010 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (38)
Prognostic value of urinary N-telopeptide (uNTx) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)